Novel, Emerging and Neglected Fungal Pathogens for Humans

Dear Colleagues,

An increasing number of fungal species are recognized as being pathogenic to humans. One of the reasons for this trend is that clinical fungi can now be more accurately identified using molecular technologies. Therefore, fungi previously uncommonly encountered can now be recognized as causes of infections. Unknown fungi of clinical origin can also be characterized via genealogical concordance approaches and described as novel species. A notable example is the recognition of the yeast Candida auris as a species distinct from Candida haemulonii and Candida ruelliae, and it is now notorious for its persistence in the environment, as well as its multi-drug-resistant properties. Knowledge of these novel, emerging and/or neglected fungal pathogens is unfortunately lacking; thus, more research into them is needed.

In this Special Issue, we invite researchers to contribute original research and review articles on novel, emerging and neglected fungal pathogens that affect humans. Topics of interest include, but are not limited to, the following subjects:

• Description of novel human pathogenic fungal species;
• Pathogenesis or virulence;
• Antifungal susceptibility and resistance;
• Epidemiology;
• Diagnostic methods;
• Any other relevant areas.

Dr. Chi-Ching Tsang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• description of novel human pathogenic fungal species
• pathogenesis or virulence
• antifungal susceptibility and resistance
• epidemiology
• diagnostic methods
• any other relevant areas